Delivery Order SPE2DB20D3103-SPE2DB25FQ2E7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,849.28 to AmerisourceBergen Drug Corp on July 22, 2025, for Atropine 0.4 mg/mL vials. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025....
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This delivery order, awarded on August 25, 2025, provides for the supply of Atropine 1 mg/ml vials to the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with a ceiling value of $8,326.68 and a firm fixed price structure. The order is scheduled for completion by August 26, 2025, and represents a non-set-aside, competitively...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $2,111.43. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Atropine 1 mg/10 mL in quantities of 10 units. This contract represents a non-set-aside, competitively awarded delivery order with firm fixed price terms and a ceiling value of $21,867.75, with an ultimate completion date of September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Atropine 1 mg/mL vials with a ceiling value of $1,435.74. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. The award represents a delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.30 to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $6,487.05, represents a non-competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2E7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,585.05 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials. This firm fixed-price contract is non-competitive and does not utilize a set-aside designation. The order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atropine is a critical emergency medical supply used in military and federal healthcare settings for various medical applications. This delivery order represents a child contract under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive federal portfolio serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to meet federal medical procurement requirements through competitive awards and its broad range of pharmaceutical product offerings position it as a critical vendor for the military's medical supply chain and federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 9/9/25 |